arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

PHIBRO ANIMAL HEALTH CORP

PAHC
$33.91 ▼ -0.19 (-0.54%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
57 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
65
Health
Good
Bullish
auto_awesome

Analytical Summary

PHIBRO ANIMAL HEALTH CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth 4.8% ↘
Op. Margin 12.1% ↗
ROIC 8.4% ↗
FCF / Share None
Trailing P/E 62.8x
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 24, 2026.

57-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$396.75M
↑ +4.8% —
Net Income Profit after all expenses
$21.71M
↑ +26.0% —
Operating Margin Operating profit as % of sales
12.1%
↑ +4.3% 73th
FCF / Share Free cash flow per share
$0.40
↓ -16.3% —
Long-Term Debt Long-term obligations
$620.52M
↓ -0.6% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
55
Returns ↑
86
Financial Health ↓
63
Cash Quality ↑
45

Dividend History

Dividend / share · sourced from SEC filings
$0.48 Latest / share
+0.0% YoY
+1.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 16 years · 57 quarters